I’m excited to announce two new cases that opened yesterday: Askel Healthcare and Sharpfin.
Askel Healthcare is a Finnish university spin-off medtech company focusing on solving joint pain caused by cartilage damage in both animals and humans. The team has put years of scientific research into the development of the COPLA Scaffold™.
Sharpfin is a Swedish software startup focused on automating the wealth management industry. The founding members have programming experience from several fintech firms and banks, and the company’s board includes ex-MD of Swiss private bank Lombard Odier and head of contract management at Ericsson.
Lasse Mäkelä, CEOAll investments carry a risk of losing capital. Invest responsibly.
Ezylet is an exciting property portal aimed at the untapped private rental market. Landlords, Agents & Tenants can access a host of property services all in one place leading to enhanced profits & better customer experience. That’s the Ezylet way!
Sharpfin lives the vision to automate the EUR 80 trillion assets wealth management industry. Invest in one of the most promising B2B Fintech companies with proven business model and growing customer base.
Highly relevant product offering within the asset management industry
Experienced team, board and advisors
Clients include Consensus Asset Management and Privat Consult
Joint pain? Often the underlying cause is cartilage damage – an unsolved medical issue affecting numerous people and animals. With the COPLA Scaffold™, healing joint surface damage to regain healthy movement is now possible.
Medtech innovation that can solve cartilage-related problems
Years of scientific research experience
Starting sales to veterinarians, later expanding to human patients
TWID is the leading online training software in Finland. Our monthly recurring revenue is currently 327.000 euros per year. When it comes to growth, we aim high. Next up are the rest of Scandinavia, the Netherlands and Russia.